£68k
+5%vs Jun 2024ActiveSC665433Private limited companyEdinburgh
DOW DRUG DEVELOPMENT SOLUTIONS LIMITED
Significant control: Margaret Sara Dow (75–100%), Robert James Dow (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Dow Drug Development Solutions Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Dow Drug Development Solutions Limited sell?
Registered activity: Other professional, scientific and technical activities n.e.c. (SIC 74909). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
DOW DRUG DEVELOPMENT SOLUTIONS LIMITED is an active private limited company (company number SC665433) incorporated on 26 June 2020, registered in Edinburgh. Its registered activity is other professional, scientific and technical activities n.e.c. (SIC 74909). Latest micro accounts cover the period ending 30 June 2025, showing net assets of £68k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 5% on the prior period (£65k).
Peer position · net assets
By net assets it sits in the top quarter of 647 comparable companies in Edinburgh (median £5,817, upper quartile £41k).
02
Ownership and control
- Mrs Margaret Sara Dow
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Robert James Dow
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 26 June 20206 yrs ago
- Next accounts due
- 30 March 2027in 153 days
- Confirmation statement due
- 10 July 2027in 255 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
No changevs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £68k | — | — | £14k | — | — | 2 |
| 30 June 2024 | £65k | — | — | £17k | — | — | 2 |
Current ratio5.58Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £67,770 at 30 June 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 5.58
- Incorporated five or more years agoIncorporated 26 June 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 255 days
- Next accounts duein 153 days
- Accounts period endNet assets £68k · micro accounts
- Accounts period endNet assets £65k · micro accounts
- Incorporated
08
Similar companies in Edinburgh
09
Reminders for DOW DRUG DEVELOPMENT SOLUTIONS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.